Kite Pharma, Inc.: cash_and_equivalents

Value{"amount": 8651000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2012-12-31)
Statuscurrent
EntityKite Pharma, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-14-003819 · Open the official SEC filing →
Retrieved: 2026-08-19T15:09:19.088139+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001510580/cash-and-equivalents/2012-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/cb7b0477-80f8-4fe8-a916-23d96f8f375f

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies